The Latin America, Middle East and Africa Sequencing Reagents Market is expected to witness market growth of 20.2% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Sequencing Reagents Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $518.8 million by 2031. The Argentina market is showcasing a CAGR of 21.8% during 2024-2031. Additionally, the UAE market would register a CAGR of 19.1% during 2024-2031.
In environmental sciences, sequencing technologies have revolutionized the study of microbial communities in diverse ecosystems. Metagenomic sequencing has provided insights into processes like carbon cycling and pollution degradation, as seen during the Deepwater Horizon oil spill cleanup, where microbial genomics guided remediation efforts. Similarly, in evolutionary biology, sequencing has unraveled genetic adaptations and evolutionary lineages, such as those revealed by comparing the genomes of Neanderthals and Denisovans with modern humans.
Additionally, conservation strategies for endangered species like tigers and elephants have also benefited from sequencing by assessing genetic diversity and population structure. These applications depend on high-quality sequencing reagents capable of handling complex and varied sample types, underscoring their importance in advancing scientific understanding across disciplines.
Countries in the region are leveraging sequencing technologies to address unique healthcare and research challenges, supported by increasing government investments and international collaborations. Governments and healthcare organizations are adopting genomic technologies to improve cancer diagnostics and treatment. In Brazil, the Genomics Initiative of the Barretos Cancer Hospital utilizes next-generation sequencing (NGS) for tumor profiling, enabling the identification of actionable mutations for targeted therapies. Similarly, in South Africa, oncology-focused programs funded by the National Research Foundation (NRF) integrate sequencing into precision medicine efforts.
The Brazil market dominated the LAMEA Sequencing Reagents Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $518.8 million by 2031. The Argentina market is showcasing a CAGR of 21.8% during 2024-2031. Additionally, the UAE market would register a CAGR of 19.1% during 2024-2031.
In environmental sciences, sequencing technologies have revolutionized the study of microbial communities in diverse ecosystems. Metagenomic sequencing has provided insights into processes like carbon cycling and pollution degradation, as seen during the Deepwater Horizon oil spill cleanup, where microbial genomics guided remediation efforts. Similarly, in evolutionary biology, sequencing has unraveled genetic adaptations and evolutionary lineages, such as those revealed by comparing the genomes of Neanderthals and Denisovans with modern humans.
Additionally, conservation strategies for endangered species like tigers and elephants have also benefited from sequencing by assessing genetic diversity and population structure. These applications depend on high-quality sequencing reagents capable of handling complex and varied sample types, underscoring their importance in advancing scientific understanding across disciplines.
Countries in the region are leveraging sequencing technologies to address unique healthcare and research challenges, supported by increasing government investments and international collaborations. Governments and healthcare organizations are adopting genomic technologies to improve cancer diagnostics and treatment. In Brazil, the Genomics Initiative of the Barretos Cancer Hospital utilizes next-generation sequencing (NGS) for tumor profiling, enabling the identification of actionable mutations for targeted therapies. Similarly, in South Africa, oncology-focused programs funded by the National Research Foundation (NRF) integrate sequencing into precision medicine efforts.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.Illumina, Inc.
Market Report Segmentation
By Type
- Sequencing Kits
- Library Kits
- Control Kits
- Template Kits
- Other Type
By Technology
- Next-Generation Sequencing
- Third Generation Sequencing
- Sanger Sequencing
By Application
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Consumer Genomics
- Other Application
By End Use
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Use
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Sequencing Reagents Market by Type
Chapter 6. LAMEA Sequencing Reagents Market by Technology
Chapter 7. LAMEA Sequencing Reagents Market by Application
Chapter 8. LAMEA Sequencing Reagents Market by End Use
Chapter 9. LAMEA Sequencing Reagents Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
- Illumina, Inc.
Methodology
LOADING...
